SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Cell MedX Corp. – ‘10-Q’ for 8/31/14 – ‘EX-3.2’

On:  Wednesday, 10/8/14, at 6:16pm ET   ·   As of:  10/9/14   ·   For:  8/31/14   ·   Accession #:  1594062-14-314   ·   File #:  0-54500

Previous ‘10-Q’:  ‘10-Q/A’ on 7/17/14 for 2/28/14   ·   Next:  ‘10-Q’ on 1/14/15 for 11/30/14   ·   Latest:  ‘10-Q’ on 4/15/24 for 2/29/24   ·   20 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

10/09/14  Cell MedX Corp.                   10-Q        8/31/14   37:2.9M                                   Ideal Connection, Inc/FA

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report -- form10q                         HTML    136K 
 2: EX-3.2      Articles of Merger ? Sports Asylum, Inc. and        HTML     16K 
                Plandel Resources, Inc.*                                         
 3: EX-3.3      Articles of Merger ? Cell Medx Corp. and Sports     HTML     16K 
                Asylum, Inc.*                                                    
 4: EX-31.1     Certification -- §302 - SOA'02                      HTML     20K 
 5: EX-32.1     Certification -- §906 - SOA'02                      HTML     17K 
23: R1          Document and Entity Information                     HTML     40K 
17: R2          Condensed Balance Sheets (Unaudited)                HTML     52K 
21: R3          Condensed Balance Sheets (Parenthetical)            HTML     21K 
25: R4          Condensed Statements of Operations (Unaudited)      HTML     30K 
34: R5          Condensed Statements of Cash Flows (Unaudited)      HTML     45K 
18: R6          Note 1 - Organization                               HTML     23K 
20: R7          Note 2 - Summary of Significant Accounting          HTML     19K 
                Policies                                                         
16: R8          Note 3 - Unproved Mineral Claim                     HTML     16K 
14: R9          Note 4 - Definitive Letter Agreement                HTML     18K 
35: R10         Note 5 - Advances Payable                           HTML     17K 
27: R11         Note 6 - Significant Transactions With Related      HTML     19K 
                Parties                                                          
26: R12         Note 7 - Common Stock                               HTML     22K 
30: R13         Note 8 - Going Concern                              HTML     18K 
31: R14         Note 9 - Subsequent Events                          HTML     18K 
29: R15         Note 2 - Summary of Significant Accounting          HTML     17K 
                Policies (Policies)                                              
32: R16         Note 1 - Organization (Details Narrative)           HTML     19K 
22: R17         Note 3 - Unproved Mineral Claim (Details            HTML     15K 
                Narrative)                                                       
24: R18         Note 4 - Definitive Letter Agreement (Details       HTML     24K 
                Narrative)                                                       
28: R19         Note 5 - Advances Payable (Details Narrative)       HTML     17K 
37: R20         Note 6 - Significant Transactions With Related      HTML     20K 
                Parties (Details Narrative)                                      
33: R21         Note 8 - Going Concern (Details Narrative)          HTML     18K 
19: R22         Note 9 - Subsequent Events (Details Narrative)      HTML     18K 
36: XML         IDEA XML File -- Filing Summary                      XML     47K 
12: EXCEL       IDEA Workbook of Financial Reports                  XLSX     33K 
15: EXCEL       IDEA Workbook of Financial Reports (.xls)            XLS     57K 
 8: EX-101.INS  XBRL Instance -- sylm-20140831                       XML     76K 
 6: EX-101.CAL  XBRL Calculations -- sylm-20140831_cal               XML     52K 
 7: EX-101.DEF  XBRL Definitions -- sylm-20140831_def                XML     33K 
 9: EX-101.LAB  XBRL Labels -- sylm-20140831_lab                     XML    175K 
10: EX-101.PRE  XBRL Presentations -- sylm-20140831_pre              XML    127K 
11: EX-101.SCH  XBRL Schema -- sylm-20140831                         XSD     50K 
13: ZIP         XBRL Zipped Folder -- 0001594062-14-000314-xbrl      Zip     22K 


‘EX-3.2’   —   Articles of Merger ? Sports Asylum, Inc. and Plandel Resources, Inc.*


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 C:   C:   C: 


ex3.2 p1
 
 
1

 
ex3.2 p2
 
 
2

 
ex3.2 p3
 
 
3

 
ex3.2 p4
 
 
4

 
ex3.2 p5
 
 
5

 
ex3.2 p6
 
 
6

 
ex3.2 p7
 
 
7

 
ex3.2 p8
 
 
8

 

20 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 4/15/24  Cell MedX Corp.                   10-Q        2/29/24   53:2.7M                                   Empire Stock Transf… Inc
 1/16/24  Cell MedX Corp.                   10-Q       11/30/23   46:2.3M                                   Empire Stock Transf… Inc
10/16/23  Cell MedX Corp.                   10-Q        8/31/23   42:1.9M                                   Empire Stock Transf… Inc
 9/01/23  Cell MedX Corp.                   10-K        5/31/23   73:3.2M                                   Empire Stock Transf… Inc
 6/29/23  Cell MedX Corp.                   10-Q        2/28/23   53:2.5M                                   Empire Stock Transf… Inc
 5/19/23  Cell MedX Corp.                   10-Q       11/30/22   53:2.4M                                   Empire Stock Transf… Inc
 4/19/23  Cell MedX Corp.                   10-Q        8/31/22   51:2.2M                                   Empire Stock Transf… Inc
 4/07/23  Cell MedX Corp.                   10-K        5/31/22   90:3.6M                                   Empire Stock Transf… Inc
 4/11/22  Cell MedX Corp.                   10-Q        2/28/22   56:2.5M                                   Empire Stock Transf… Inc
 1/12/22  Cell MedX Corp.                   10-Q       11/30/21   54:2.4M                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   424B3                  1:365K                                   Empire Stock Transf… Inc
10/14/21  Cell MedX Corp.                   10-Q        8/31/21   50:2.2M                                   Empire Stock Transf… Inc
10/12/21  Cell MedX Corp.                   424B3                  1:705K                                   Empire Stock Transf… Inc
 8/30/21  Cell MedX Corp.                   10-K        5/31/21   83:3.7M                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   424B3                  1:501K                                   Empire Stock Transf… Inc
 4/09/21  Cell MedX Corp.                   10-Q        2/28/21   56:2.8M                                   Empire Stock Transf… Inc
 3/04/21  Cell MedX Corp.                   S-1                   78:3.8M                                   Empire Stock Transf… Inc
 1/14/21  Cell MedX Corp.                   10-Q       11/30/20   53:2M                                     Empire Stock Transf… Inc
10/15/20  Cell MedX Corp.                   10-Q        8/31/20   51:1.9M                                   Empire Stock Transf… Inc
 9/15/20  Cell MedX Corp.                   10-K        5/31/20   84:2.9M                                   Empire Stock Transf… Inc
Top
Filing Submission 0001594062-14-000314   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 27, 10:29:02.2am ET